Aisner J., Wiernik PH, Pearl P.: Pregnancy outcome in patients treated for Hodgkin's disease. J Clin Oncol11(3):507-512, 1993
2.
Anderson JR, Jenkin Rdt, Wilson JF, et al: Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin's lymphoma: A report of CCG-551 from the Childrens Cancer Group. J Clin Oncol11(6):1024-1032, 1993
3.
Ascher DP, Shoupe BA, Maybee D., et al: Persistent catheter-related bacteremia: Clearance with antibiotics and urokinase. J Pediatr Surg28(4):627-629, 1993
4.
Åström G., Jansson L., Norberg A., et al: Experienced nurses' narratives of their being in ethically difficult care situations: The problem to act in accordance with one's ethical reasoning and feelings. Cancer Nurs16(3):179-187, 1993
5.
Beckwith JB: Precursor lesions of Wilms' tumor: Clinical and biological implications. Med Pediatr Oncol21(3):158-168, 1993
6.
Berro EA, Bechler-Karsch A.: A closer look at septic shock. Pediatr Nurs19(3):289-297, 1993
7.
Billett AL, Sallan SE: Autologous bone marrow transplantation in childhood acute lymphoid leukemia with use of purging. Am J Pediatr Hematol Oncol15(2):162-168, 1993
8.
Breslow N., Olshan A., Beckwith JB, et al: Epidemiology of Wilms' tumor. Med Pediatr Oncol21(3):172-181, 1993
9.
Bruner DW: Radiation oncology nurses: Staffing patterns and role development. Oncol Nurs Forum20(4):651-655, 1993
10.
Bunin GR, Meadows AT: Epidemiology and Wilms' tumor: Approaches and methods. Med Pediatr Oncol21(3):169-171, 1993
11.
Campbell LA, Seeger RC, Harris RE, et al: Escalating dose of continuous infusion combination chemotherapy for refractory neuroblastoma. J Clin Oncol11(4):623-629, 1993
12.
Carroll P.: Clinical application of pulse oximetry. Pediatr Nurs19(2):150-151, 1993
13.
Children's Hospice International: Standards of hospice care for children. Pediatr Nurs19(3):242-243, 1993
14.
Chisholm LG, Berman AR, de Carvalho M, et al: Programmed instruction: Cancer chemotherapy: Alternative administration routes. Cancer Nurs16(3): 237-246, 1993
15.
Clark PJ, Byrne MW: Clinical issues in long-term pediatric HIV disease (part II). MCN18(3):164-167, 1993
16.
Clericuzio CLClinical phenotypes and Wilms' tumor. Med Pediatr Oncol21(3):182-187, 1993
17.
Clericuzio CL, D'Angio GJ, Duncan M., et al: Summary and recommendations of the workshop held at the First International Conference on Molecular and Clinical Genetics of Childhood Renal Tumors, Albuquerque, New Mexico, May 14-16, 1992. Med Pediatr Oncol 21(3):233-236, 1993
18.
Coppes MJ: Serum biological markers and paraneoplastic syndromes in Wilms' tumor. Med Pediatr Oncol121(3):213-221, 1993
19.
Damrosch S., Denicoff AM, St. Germain D., et al: Oncology nurse and physician attitudes toward aggressive cancer treatment. Cancer Nurs16(2):107-112,1993
20.
D'Angio GJ, Rosenberg H., Sharples K., et al: Position paper: Imaging methods for primary renal tumors of childhood: Costs versus benefits. Med Pediatr Oncol21(3):205-212,1993
21.
Davies B., Eng B.: Survey of nursing research programs in children's hospitals. J Pediatr Nurs8(3): 159-166, 1993
22.
Davis K.: The accuracy of tympanic temperature measurement in children. Pediatr Nurs19(3):267-272, 1993
23.
Ferrell BR, Taylor EJ, Grant M., et al: Pain management at home: Struggle, comfort, and mission. Cancer Nurs16(3):169-178, 1993
24.
Filocoma D., Needleman HL, Arceci R., et al: Pediatric histiocytosis: Characterization, prognosis, and oral involvement. Am J Pediatr Hematol Oncol15(2): 226-230, 1993
25.
Fink FM, Köller U., Mayer H., et al: Prognostic significance of myeloid-associated antigen expression on blast cells in children with acute lymphoblastic leukemia. Med Pediatr Oncol21 (5):340-346, 1993
26.
Gamis AS, Haake R., McGlave P., et al: Unrelated-donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in children. J Clin Oncol11(5):834-838, 1993
27.
Grassman D.: Development of inpatient oncology educational and support programs. Oncol Nurs Forum20(4):669-676, 1993
28.
Green DM, Breslow NE, Beckwith JB, et al: Screening of children with hemihypertrophy, aniridia, and Beckwith-Wiedemann syndrome in patients with Wilms' tumor: A report from the National Wilms'
29.
Tumor Study. Med Pediatr Oncol21(3):188-192, 1993
30.
Green DM, Breslow NE, D'Angio GJ: The treatment of children with unilateral Wilms' tumor. J Clin Oncol11(6):1009-1010, 1993 (editorial)
31.
Gruppo RA: Neuropsychologic consequences of long-term human immunodeficiency virus infection: The Hemophilia Growth and Development Study. Am J Pediatr Hematol Oncol15(2):204-207, 1993
32.
Hagopian GA: Cognitive strategies used in adapting to a cancer diagnosis. Oncol Nurs Forum20(5):759-763, 1993
33.
Harms D., Schmidt D.: Critical commentary: Rare tumors in childhood: Pathological aspects. Experience of the Kiel Pediatric Tumor Registry. Med Pediatr Oncol21(4):239-248, 1993
34.
Henslee-Downey PJ: Choosing an alternative bone marrow donor among available family members. Am J Pediatr Hematol Oncol15(2):150-161, 1993
35.
Hollen PJ, Hobbie WL: Risk taking and decision making of adolescent long-term survivors of cancer . Oncol Nurs Forum20(5):769-776, 1993
36.
Jakacki RI, Goldwein JW, Larsen RL, et al: Cardiac dysfunction following spinal irradiation during childhood . J Clin Oncol11(6):1033-1038, 1993
37.
Johnson LC, Rincon B., Gober C., et al: The development of a comprehensive bereavement program to assist families experiencing a pediatric loss. J Pediatr Nurs8(3):142-146, 1993
38.
Kagan AR, Steckel RJ: Critical commentary: Diagnostic imaging in the surveillance of treated children with cancer. Med Pediatr Oncol21(5):323-326, 1993
39.
Kingma A., Mooyaart EL, Kamps WA, et al: Magnetic resonance imaging of the brain and neuropsychological evaluation in children treated for acute lymphoblastic leukemia at a young age. Am J Pediatr Hematol Oncol15(2):231-238, 1993
40.
Kiss ME, Dorsa BA, Martin S.: The development of a patient history and data base form. Oncol Nurs Forum20(5):815-823, 1993
41.
Knudson AG Jr: Introduction to the genetics of primary renal tumors in children. Med Pediatr Oncol21(3):193-198, 1993
42.
Lin EM, Tierney DK, Stadtmauer EA: Autologous bone marrow transplantation: A review of the principles and complications . Cancer Nurs16(3):204-213, 1993
43.
Marina NM, Rodman J., Shema SJ, et al: Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in children with relapsed solid tumors. J Clin Oncol11(3):554-560, 1993
44.
Méresse V., Vassal G., Michon J., et al: Combined continuous infusion etoposide with high-dose cyclophosphamide for refractory neuroblastoma: A phase II study from the Société Française d'Oncologie Pédiatrique.J Clin Oncol11(4):630-635, 1993
45.
Meyers PA, Heller G., Healey JH, et al: Osteogenic sarcoma with clinically detectable metastasis at initial presentation. J Clin Oncol11(3):449-453, 1993
46.
Nelson SC, Friedman HS, Hockenberger B., et al: False-positive MRI detection of recurrent or metastatic pediatric infratentorial tumors. Med Pediatr Oncol21(5):350-355, 1993
47.
Hewsham I., Cavenee W.: Tumors and developmental anomalies associated with Wilms' tumor. Med Pediatr Oncol21 (3):199-204, 1993
48.
Packer RJ, Lange B., Ater J., et al: Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood. J Clin Oncol11(5): 850-856, 1993
49.
Pappo AS, Vats T., Williams TE, et al: Phase I trial of trimetrexate in pediatric solid tumors: A Pediatric Oncology Group study. Med Pediatr Oncol21(4): 280-282, 1993
50.
Partin AW, Gearhart JP, Leonard MP, et al: The use of nuclear morphometry to predict prognosis in pediatric urologic malignancies: A review. Med Pediatr Oncol21(3):222-229, 1993
51.
Petrilli AS, Bianchi A., Kusano E., et al: Fever and granulocytopenia in children with cancer. A study of 299 episodes with two treatment protocols in Brazil. Med Pediatr Oncol21(5):356-361, 1993
52.
Pevny V.: Outcome of a quality assurance review: Development of a documentation tool for chemotherapy administration. Oncol Nurs Forum20(3):535-541,1993
53.
Plantaz D., Hartmann O., Kalifa C., et al: Localized dumbbell neuroblastoma: A study of 25 cases treated between 1982 and 1987 using the same protocol. Med Pediatr Oncol21(4):249-253, 1993
54.
Pullen J., Boyett J., Shuster J., et al: Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor-risk patients with B-progenitor acute lymphoblastic leukemia: A Pediatric Oncology Group study. J Clin Oncol11(5):839-849, 1993
55.
Revesz T., Orban T., DeBuse P.: Transient respiratory depression in two patients with Down's syndrome following midazolam premedication. Med Pediatr Oncol21(5):384, 1993 (letter)
56.
Robertson J.: Pediatric pain assessment: Validation of a multidimensional tool. Pediatr Nurs19(3):209-213, 1993
57.
Sabbaga CC, Avilla SA, Schulz C., et al: Adrenocortical carcinoma in children: Clinical aspects and prognosis . J Pediatr Surg28(6):841-843, 1993
58.
Sandoval C., Pui CH, Bowman LC, et al: Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation . J Clin Oncol11(6):1039-1045, 1993
59.
Sands DA, Galassi A., Chisholm L., et al: A cancer day hospital: An alternative approach to caring for patients in clinical trials. Oncol Nurs Forum20(5): 787-793, 1993
60.
Sanford CC: Ronald McDonald House—The house that love built. Pediatr Nurs19(3):260-262, 1993
61.
Schuler D., Somló P., Koós R., et al: The treatment of malignant scala posterior tumors in children: II. Preliminary result of the pre- and postoperative adjuvant chemotherapy of scala posterior tumors. Med Pediatr Oncol21(4):274-279, 1993
62.
Singer JW: Use of recombinant hematopoietic growth factors in bone marrow transplantation . Am J Pediatr Hematol Oncol15(2):175-184, 1993
63.
Smith MD Jr, Nio M., Camel JE, et al: Management of splenic abscess in immunocompromised children . J Pediatr Surg28(6):823-826, 1993
64.
Sosman JA, Sondel PM: The graft-vs.-leukemia effect: Implications for post-marrow transplant antileukemia treatment. Am J Pediatr Hematol Oncol15(2): 185-195,1993
65.
Tournade MF, Com-Nougué C., Voûte PA, et al: Results of the Sixth International Society of Pediatric Oncology Wilms' Tumor Trial and Study: A risk-adapted therapeutic approach in Wilms' tumor. J Clin Oncol11(6):1014-1023, 1993
66.
Trigg ME: Bone marrow transplantation using alternative donors: Mismatched related donors or closely matched unrelated donors. Am J Pediatr Hematol Oncol15(2):141-149, 1993
67.
Tubergen DG, Gilchrist GS, O'Brien RT, et al: improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: A Childrens Cancer Group phase III trial. J Clin Oncol11(3):527-537, 1993
68.
Tubergen DG, Gilchrist GS, O'Brien RT, et al: Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: Comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: A Childrens Cancer Group report. J Clin Oncol11(3):520-526, 1993
69.
Tura S., Fiancchini M., Zinzani PL, et al: Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease. J Clin Oncol11(5):925-930, 1993
70.
Van Cleve LJ, Savedra MC: Pain location: Validity and reliability of body outline markings by 4 to 7-year old children who are hospitalized. Pediatr Nurs19(3):217-220, 1993
Wallace Whb, Shalet SM, Tetlow JL, et al: Ovarian function following the treatment of childhood acute lymphoblastic leukaemia. Med Pediatr Oncol21(5): 333-339, 1993
73.
Wells RJ, Woods WG, Lampkin BC, et al: Impact of high-dose cytarabine and asparaginase intensification on childhood acute myeloid leukemia: A report from the Childrens Cancer Group . J Clin Oncol11(3):538-545, 1993
74.
Wolfrom C., Hartmann R., Fengler R., et al: Randomized comparison of 36-hour intermediate-dose versus 4-hour high-dose methotrexate infusions for remission induction in relapsed childhood acute lymphoblastic leukemia. J Clin Oncol11(5):827-833, 1993
75.
Young A., Volker D., Rieger PT, et al: Oncology nurses' attitudes regarding voluntary, physician-assisted dying for competent, terminally ill patients. Oncol Nurs Forum20(3):445-451, 1993
76.
Zerbini C., Gelber RD, Weinberg D., et al: Prognostic factors in medulloblastoma, including DNA ploidy . J Clin Oncol11(4):616-622, 1993
